Abstract:Background Tuberculosis (TB) remains a major public health concern worldwide. Previous studies have demonstrated that IL-17 plays an important role in initial immune response and is involved in both immune-mediated protection and pathology following infection with Mycobacterium tuberculosis (MTB). However, the alterations and regulation of plasma IL-17 level during TB treatment remain unclear. Moreover, the cell type responsible for the production of IL-17 in TB patients requires further study. Methods A total of 20 acid-fast bacilli smear-positive (AFB-positive) pulmonary TB patients and 20 age- and gender-matched healthy volunteers were included in our study. Blood samples were collected in heparinized tubes at the time of diagnosis (AFB-positive group) and 3 weeks after the initiation of therapy, when the sputum smear conversion (AFB-negative group) occurred, followed by symptomatic improvement. IL-17 levels and IL-17-producing cells in PBMCs were detected. Lymphocyte populations in the peripheral blood between the AFB-positive and AFB-negative groups were compared by flow-cytometry. A549 cells, a cell line of alveolar epithelial cells, were applied to determine the extent of the pathological damage mediated by IL-17 following MTB infection. Recombinant human IL-10 was used to investigate the regulation of IL-17 expression after sputum smear conversion in AFB-positive pulmonary TB patients. Results Plasma IL-17 level were elevated in patients with sputum AFB-positive pulmonary TB, but substantially decreased after TB treatment and smear conversion. Our data indicate that NKT-like cells might be the main source of IL-17, in addition to conventional T cells in AFB-positive pulmonary TB patients. The secretion of IL-17 may be suppressed by regulatory T (Treg) cells and IL-10 during TB treatment. Moreover, the IL-17 levels were positively correlated to both the C-reactive protein and erythrocyte sedimentation rate. Therefore, IL-17 was capable of alveolar epithelial cell damage following MTB infection. Conclusion The increase in the frequency of Treg cells and IL-10 levels was associated with a decrease in IL-17 in patients receiving TB treatment. Thus, IL-10 and Tregs may function to inhibit immune-mediated pathology in TB patients.

Anti-tuberculosis Treatment Enhances the Production of IL-22 Through Reducing the Frequencies of Regulatory B Cell.

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

CD11b(+) Dendritic Cell-Mediated Anti-Mycobacterium Tuberculosis Th1 Activation is Counterregulated by CD103(+) Dendritic Cells Via IL-10

The Expressions and Roles of Different Forms of IL-22 in Mycobacterium Tuberculosis Infection.

Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells Suppress Mycobacterium Tuberculosis Immunity in Patients with Active Disease

Selective Destruction of Interleukin 23-Induced Expansion of a Major Antigen-Specific γδ T-Cell Subset in Patients With Tuberculosis.

The immune characterization of interferon-β responses in tuberculosis patients

Interleukin-26 expression in tuberculosis disease and its regulatory effect in macrophage polarization and intracellular elimination of Mycobacterium tuberculosis

CTLA-4 Blockade Reverses the Foxp3+ T-regulatory-cell Suppression of Anti-Tuberculosis T-cell Effector Responses

Innate lymphoid cells exhibited IL-17-expressing phenotype in active tuberculosis disease

B cell infiltration is associated with the increased IL-17 and IL-22 expression in the lungs of patients with tuberculosis

Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection

Ablation of B cell-derived IL-10 increases tuberculosis resistance

Elevation in the counts of IL-35-producing B cells infiltrating into lung tissue in mycobacterial infection is associated with the downregulation of Th1/Th17 and upregulation of Foxp3+Treg

IL-27 attenuated macrophage injury and inflammation induced by Mycobacterium tuberculosis by activating autophagy

Mycobacterium tuberculosis hijacks host macrophages-derived interleukin 16 to block phagolysosome maturation for enhancing intracellular growth

Characterization of Membrane-Bound IL-22+ T Cell Subsets in HIV-1 Patients Coinfected with Mycobacterium Tuberculosis.

IFNγ-secreting T cells that highly express IL-2 potently inhibit the growth of intracellular M. tuberculosis in macrophages

T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection

IL-37 Confers Protection Against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation

Increased Frequency of ILT2-expressing CD56dimCD16+ NK Cells Correlates with Disease Severity of Pulmonary Tuberculosis